Cargando…
Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR
INTRODUCTION: Pre-emptive testing of pharmacogenetically relevant single-nucleotide polymorphisms can be an effective tool in the prevention of adverse drug reactions and therapy resistance. However, most of the tests are not used as standard in routine care in Germany because of lacking evidence fo...
Autores principales: | Huebner, Tatjana, Steffens, Michael, Linder, Roland, Fracowiak, Jochen, Langner, Daria, Garling, Marco, Falkenberg, Felix, Roethlein, Christoph, Gomm, Willy, Haenisch, Britta, Stingl, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213853/ https://www.ncbi.nlm.nih.gov/pubmed/32345696 http://dx.doi.org/10.1136/bmjopen-2019-032624 |
Ejemplares similares
-
Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes
por: Fracowiak, Jochen, et al.
Publicado: (2022) -
Hyperuricemia and dementia – a case-control study
por: Engel, Bettina, et al.
Publicado: (2018) -
Costs of coordinated versus uncoordinated care in Germany: results of a routine data analysis in Bavaria
por: Schneider, Antonius, et al.
Publicado: (2016) -
Impact of the abolition of copayments on the GP-centred coordination of care in Bavaria, Germany: analysis of routinely collected claims data
por: Olm, Michaela, et al.
Publicado: (2020) -
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study
por: Just, Katja S., et al.
Publicado: (2020)